FDA takes steps to ease fears over hormone therapy for menopause

WASHINGTON, D.C.—The U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) announced on Monday, November 10, a series of measures aimed at updating guidance on hormone replacement therapy (HRT) for menopausal women, including the removal of longstanding “black box” warnings from certain products. “Today, we are standing up for […]